Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image
- PMLiVE

Pharmaceutical Market Europe – November 2023

A focus on real-world evidence and its capabilities; transforming clinical trials with connected drug devices; the impact of AI and ChatGPT on pharma

- PMLiVE

Pharmaceutical Market Europe – October 2023

Launch excellence – adapting to data disruption; preparing for the clinical trials of the future; the impact of cell therapies on cancer treatments

- PMLiVE

Pharmaceutical Market Europe – September 2023

Accelerating clinical trial diversity; the fight against AMR; innovation in chronic diseases; the importance of actinic keratosis awareness

- PMLiVE

Pharmaceutical Market Europe – July/August 2023

Communiqué Awards 2023: celebrating 25 years! See page 26 for full coverage of the event; Creating truly effective communications excellence

- PMLiVE

Pharmaceutical Market Europe – June 2023

Powering creativity to work in harmony with science and data; Driving conscious inclusion in companies; AI – the next paradigm shift in healthcare

- PMLiVE

Pharmaceutical Market Europe – May 2023

Achieving better patient pathways with a focus on the patient; Why TB remains a major global public health challenge; The impact of rare diseases

- PMLiVE

Pharmaceutical Market Europe – April 2023

New beginnings – learning the language of change; Future-proofing clinical development; Supply chain challenges faced by the pharma industry

- PMLiVE

Pharmaceutical Market Europe – March 2023

How congresses are boosting their impact and engagement; improving cardiovascular disease awareness; the importance of addressing health inequalities

- PMLiVE

Pharmaceutical Market Europe – February 2023

World Cancer Day – uniting the global cancer community, Innovation in healthcare, Life sciences reimagined – reassessing future healthcare priorities

- PMLiVE

Pharmaceutical Market Europe – January 2023

Healthcare’s rising challenges and the use of digital innovation. ASH 2022: five trends driving changes in haematology, the benefits of biosimilars

- PMLiVE

Pharmaceutical Market Europe – December 2022

Sustainability and corporate social responsibility; addressing cardiovascular disease with sustainable interventions; PMEAs 2022: A celebration of healthcare excellence

- PMLiVE

Pharmaceutical Market Europe – November 2022

The age of diversity, equality and inclusion; the patient voice in digital transformation; how telemonitoring can improve patient treatment